NCT07033234View on ClinicalTrials.gov

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118

PHASE1RecruitingINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

May 16, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Psoriasis
Interventions
DRUG

HS-20118

HS-20118

Trial Locations (1)

Unknown

RECRUITING

Affiliated Hangzhou First People's Hospital, Hangzhou

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY